JO
ONCR

John Overdeck’s Oncorus, Inc. ONCR Stock Holding History

John Overdeck’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-51,680
Closed -$17.8K – 3397
2023
Q1 		$17.8K Sell
51,680
-11,112
-18% -$4.15K ﹤0.01% 2857
2022
Q4 		$15.9K Sell
62,792
-18,700
-23% -$10.6K ﹤0.01% 2700
2022
Q3 		$69K Sell
81,492
-19,500
-19% -$25K ﹤0.01% 2274
2022
Q2 		$127K Sell
100,992
-52,634
-34% -$71.5K ﹤0.01% 2240
2022
Q1 		$273K Buy
153,626
+63,908
+71% +$179K ﹤0.01% 2243
2021
Q4 		$473K Buy
89,718
+58,965
+192% +$457K ﹤0.01% 3303
2021
Q3 		$287K Buy
+30,753
New +$351K ﹤0.01% 3708
2021
Q2 		– Sell
-31,405
Closed -$437K – 4723
2021
Q1 		$437K Buy
+31,405
New +$650K ﹤0.01% 3055

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

John Overdeck's ONCR Position: Q2 2023 in Review

John Overdeck sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 51,680 shares — an estimated $17.8K sold.

John Overdeck first reported a position in ONCR in Q1 2021 and held it in 8 quarters. The position peaked at $473K in Q4 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • John Overdeck reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • John Overdeck sold 51,680 Oncorus, Inc. shares in Q2 2023, an estimated $17.8K.
  • John Overdeck first reported a position in Oncorus, Inc. in Q1 2021 and held it in 8 quarters.
  • John Overdeck's Oncorus, Inc. position peaked at $473K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.